Phase
Condition
Allergies & Asthma
Rhinitis, Allergic, Perennial
Acute Rhinitis
Treatment
N/AClinical Study ID
Ages 18-50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18 to 50 years of age (inclusive)
Body Mass Index (BMI) between 18 and 28 kg/m2
History of pollen-induced seasonal allergic rhinitis for at least two years andotherwise healthy
Elevated specific IgE to at least one aero allergen or at least one positive skin picktest (SPT)
Seasonal allergic rhinitis with symptoms provoked by the allergen with a correspondingelevated specific IgE or positive SPT
Signed written Informed Consent
Exclusion
Exclusion Criteria:
Perennial allergic rhinitis except for cat and/or dog sensitivity under the conditionthat these patients are not exposed to cats and dogs
Soy bean allergy
Peanut allergy
Smoking during the last month before study inclusion
Any upper respiratory tract infection during the period of 2 weeks before the start ofthe study
Chronic medication
Any medication, including herbal medicines, during their last five half-lives (t½)
Nasal anatomical deviations
Extensive use of nasal sprays as judged by the Investigator
Ongoing nasal symptoms as judged by the Investigator
Known hypersensitivity to cetirizine
Pregnant or breast-feeding women
Fertile women not using reliable methods of contraception (i.e. IUD, barrier method,hormonal contraceptives, abstinence)
Participation in any other investigational study in the last three months
Inability to adhere to the study plan
Previous inclusion in this study
Blood donation during the last three months
Study Design
Study Description
Connect with a study center
Department of Otorhinolaryngology, Lund University Hospital
Lund, SE-221 85
SwedenSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.